Merck & Co., Inc.
MRK
$87.37
$1.291.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 63.62B | 63.92B | 64.17B | 63.17B | 62.48B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.62B | 63.92B | 64.17B | 63.17B | 62.48B |
| Cost of Revenue | 14.37B | 14.66B | 14.70B | 14.79B | 15.13B |
| Gross Profit | 49.25B | 49.27B | 49.47B | 48.39B | 47.35B |
| SG&A Expenses | 10.13B | 10.19B | 10.10B | 10.05B | 9.85B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.77B | 41.61B | 41.38B | 46.38B | 43.97B |
| Operating Income | 21.85B | 22.31B | 22.79B | 16.79B | 18.51B |
| Income Before Tax | 19.16B | 20.17B | 19.94B | 13.72B | 15.25B |
| Income Tax Expenses | 2.74B | 2.72B | 2.80B | 1.56B | 1.50B |
| Earnings from Continuing Operations | 16.42K | 17.45K | 17.13K | 12.16K | 13.75K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.00M | -17.00M | -16.00M | -15.00M | -16.00M |
| Net Income | 16.41B | 17.43B | 17.12B | 12.15B | 13.74B |
| EBIT | 21.85B | 22.31B | 22.79B | 16.79B | 18.51B |
| EBITDA | 26.23B | 26.69B | 27.03B | 20.83B | 22.38B |
| EPS Basic | 6.50 | 6.89 | 6.75 | 4.79 | 5.42 |
| Normalized Basic EPS | 5.23 | 5.32 | 5.42 | 3.94 | 4.29 |
| EPS Diluted | 6.49 | 6.87 | 6.73 | 4.77 | 5.39 |
| Normalized Diluted EPS | 5.22 | 5.31 | 5.40 | 3.92 | 4.28 |
| Average Basic Shares Outstanding | 10.10B | 10.13B | 10.14B | 10.13B | 10.14B |
| Average Diluted Shares Outstanding | 10.12B | 10.15B | 10.17B | 10.16B | 10.17B |
| Dividend Per Share | 3.16 | 3.12 | 3.08 | 3.04 | 3.00 |
| Payout Ratio | 48.95% | 45.54% | 45.80% | 63.72% | 55.64% |